{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T13:14:44Z","timestamp":1713186884411},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In January 2019, the use of the UroVysion\u00ae urine test for surveillance of non-muscle invasive bladder cancer with carcinoma in situ (CIS) was approved in Japan. Clinical evidence of its use remains limited. Herein, we report the real-world clinical practice of the UroVysion test. Of 29 patients underwent at least one UroVysion test at our hospital from 2019 to 2022, only two (6.9%) tested positive without any visible tumor on the cystoscopy after the initial transurethral resection: a 77-year-old man with T1 high-grade tumor and concomitant CIS and a 76-year-old woman with CIS. The remaining 27 patients (93.1%) tested negative post-transurethral resection. This study was the first to report the Japanese real-world practice of the UroVysion test, demonstrating relatively low positive rate as compared to the previous reports from other countries. Further clinical evidence from other Japanese institutes needs to be accumulated to update the true value of this test.<\/jats:p>","DOI":"10.1093\/jjco\/hyad029","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T11:05:01Z","timestamp":1681211101000},"page":"629-632","source":"Crossref","is-referenced-by-count":1,"title":["Clinical practice of UroVysion\u00ae urine test in patients with bladder carcinoma <i>in situ<\/i> treated with intravesical Bacillus Calmette\u2013Guerin"],"prefix":"10.1093","volume":"53","author":[{"given":"Makito","family":"Miyake","sequence":"first","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Hori","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Diagnostic Pathology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oda","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Tomizawa","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Morizawa","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Gotoh","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakai","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Torimoto","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"},{"name":"Nara Medical University Department of Prostate Brachytherapy, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Nara Medical University Department of Urology, , Kashihara, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"2023063007014594500_ref1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2023063007014594500_ref2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"2023063007014594500_ref3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/iju.14210","article-title":"Clinical practice guidelines for bladder cancer 2019 edition by the Japanese Urological Association: revision working position paper","volume":"27","author":"Matsumoto","year":"2020","journal-title":"Int J Urol"},{"key":"2023063007014594500_ref4","first-page":"251","article-title":"Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma","volume":"10","author":"Miyake","year":"2018","journal-title":"Res Rep Urol"},{"key":"2023063007014594500_ref5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s10147-018-1311-6","article-title":"Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan","volume":"23","author":"Kojima","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"2023063007014594500_ref6","first-page":"140","article-title":"Clinical management of bladder cancer: a novel urine diagnostic test \u2018UroVysion\u2019","volume":"65","author":"Miyake","year":"2019","journal-title":"Mod Med"},{"key":"2023063007014594500_ref7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1267\/ahc.11048","article-title":"Significant correlation between chromosomal aberration and nuclear morphology in urothelial carcinoma","volume":"45","author":"Shuto","year":"2012","journal-title":"Acta Histochem Cytochem"},{"key":"2023063007014594500_ref8","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.21037\/tau-20-1207","article-title":"UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives","volume":"10","author":"Nagai","year":"2021","journal-title":"Transl Androl Urol"},{"key":"2023063007014594500_ref9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2288-11-40","article-title":"Opt-out as an acceptable method of obtaining consent in medical research: a short report","volume":"11","author":"Vellinga","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2023063007014594500_ref10","doi-asserted-by":"crossref","first-page":"e12227","DOI":"10.1097\/MD.0000000000012227","article-title":"The role of fluorescence in situ hybridization to predict patient response to intravesical bacillus Calmette-Gu\u00e9rin therapy for bladder cancer: a diagnostic meta-analysis and systematic review","volume":"97","author":"Bao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2023063007014594500_ref11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10147-020-01634-9","article-title":"Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan","volume":"25","author":"Ikeda","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"2023063007014594500_ref12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of nonmuscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"2023063007014594500_ref13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.juro.2011.10.144","article-title":"Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Gu\u00e9rin therapy for bladder cancer: results of a prospective trial","volume":"187","author":"Kamat","year":"2012","journal-title":"J Urol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/53\/7\/629\/50738035\/hyad029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/53\/7\/629\/50738035\/hyad029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T07:02:12Z","timestamp":1688108532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/53\/7\/629\/7111526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":13,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4,10]]},"published-print":{"date-parts":[[2023,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyad029","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,4,10]]}}}